Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05889117 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Brain Stimulation for Concussion

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Apr 2025 to Apr 1, 2025
    • Study completion date: May 2025 to May 2026
    v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Dec 2024 to Apr 2025
    • Study completion date: Dec 2024 to May 2025
    • Site details revised
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2023 to Oct 30, 2023
    v3
  4. Start date: Jun 2023 to Nov 2023v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to test a new type of magnetic brain stimulation in patients with persistent post-concussive symptoms. Participants will undergo detailed MRI scans before and after 30 treatment sessions (of 3-10 minutes each). The main questions the study aims to answer are: * Will this new type of treatment result in fewer symptoms and better daily functioning? * What are the effects of this treatment on brain functioning?
Trial Details
NCT Number NCT05889117
Lead Sponsor The Mind Research Network
Collaborators: University of New Mexico
Conditions
(from sponsor)		 Transcranial Magnetic Stimulation, Magnetic Resonance Imaging, Neuropsychological Tests, Traumatic Brain Injury, Post-Concussion Syndrome
Related terms Brain Injuries, Traumatic, Post-Concussion Syndrome
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov